europhysiological analysis of developmental disorders: an exploratory neuroimaging study using functional near-infrared spectroscopy (fNIRS)

Not Applicable

Recruiting

• Conditions: ADHD

• Registration Number: JPRN-UMIN000007799
• Lead Sponsor: Department of Neurosurgery, Jichi Medical University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-07-01
• Study Completion: 2013-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who are diagnosed with anxiety disorder (2) Subjects who are diagnosed with glaucoma (3) Subjects who are diagnosed with hyperthyroidism (4) Subjects who have angina, arrhythmia (5) Subjects who have allergies to ATX (6) Subjects who are diagnosed with tics or Tourette's syndrome, or have family history of Tourette's syndrome (7) Subjects who are diagnosed with severe depression (8) Subjects who are diagnosed with pheochromocytoma (9) Subjects who current or past use of monoamine oxidase inhibitor (MAOI)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
(1) fNIRS analysis Comparison of frontal activation (Oxy-Hb) before and after an acute clinical dose of ATX or placebo (90 min after ATX administration)

Secondary Outcome Measures

Name	Time	Method
The response of continous administration of ATX on ADHD rating scale and Questionnaire-Children with Difficulties.